Acepodia, Inc. Logo

Acepodia, Inc. (6976)

TWSE

Currency in TWD
13.40
-0.10 (-0.74%)

Closed

Oct 8, 2026

Day's Range

13.20
13.55

52 wk Range

10.85
17.40

Overview - 6976 - Acepodia, Inc.

Key Statistics

Valuation

Enterprise Value

4.25B

P/E (Trailing)

‪61.21‬

Price / Sales (TTM)

‪40,328.10‬

Price / Book

‪1.47‬

EV / EBITDA

‪-4.48‬

Profitability

Profit Margin

‪65.40%‬

Operating Margin

‪-409,336.21%‬

Return on Assets

‪-11.35%‬

Return on Equity

‪-15.77%‬

Ownership

Shares Outstanding

582.86M

Float

298.22M

Held by Insiders

‪0.00%‬

Held by Institutions

‪0.03%‬

Price stats

Beta

‪0.51‬

50-Day Avg

‪12.32‬

200-Day Avg

‪13.03‬

Dividends

Payout Ratio

‪0.00%‬

News Teaser - 6976 - Acepodia, Inc.

News & Analysis

View all news

Market Cap - 6976 - Acepodia, Inc.

Peers - 6976 - Acepodia, Inc.

Peer Comparison

Compared with companies in Biotechnology listed on TWSE.

Profile Summary - 6976 - Acepodia, Inc.

About

Acepodia, Inc. is a clinical-stage biotechnology company specializing in pioneering cell therapies aimed at transforming cancer treatment. The company's primary focus lies in its proprietary Antibody-Cell Conjugation (ACC) platform, a technology that directly links tumor-targeting antibodies to immune cells such as…

SectorHealthcare
IndustryBiotechnology
Employees0
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.